Search is Powered by Google
Tropical Diseases News

Eastland Medical Systems (ASX:EMS) Receive Regulatory Approval For Anti-Malaria Treatment

Main Category: Tropical Diseases
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 21 Jan 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Eastland Medical Systems Ltd (ASX: EMS) remains on track with the development of its anti-malaria treatment ArTiMistTM and will commence a multi dose Phase 1 clinical trial for ArTiMistTM in February, after its Pharmaceutical Division receiving approval from the South African MCC Regulatory Body.

The commencement of the multi dose Phase 1 clinical trial follows the positive single dose trial recently undertaken by the company in Malaysia and is the next step in the commercialisation of this revolutionary anti-malaria treatment.

The trial will be overseen by Eastland's clinical trial consultant ProtoPharma Ltd, headed by Director of Development Mr. Calvin Ross.

This latest trial will allow the Eastland Group to progress the development of ArTiMistTM in-line with its forecasts and will see Phase 3 field treatment trials using ArTiMistTM commence in Africa and during Quarter 2 2008.

The Eastland Gro! up in co-operation with HC Berlin Pharma AG hold the exclusive! rights to develop, distribute and manufacture the new anti-malaria treatment ArTiMistTM which uses a new sublingual (under the tongue) method to administer the treatment throughout Africa, India, Asia, and the Pacific Islands.

This treatment for Malaria in young infants and children uses the unique multiple dose spray device for "Sublingual" delivery of a formulation containing the drug known as Artemether. The use of the sublingual mouth spray ArTiMistTM offers both an easier method of administration, and a more hygienic method. It is, also very easy to use even in the most remote locations often found in Africa.

Eastland CEO Dermot Patterson said, "The commencement of the multi dose trial moves the company and its global group closer to market entry for ArTiMistTM in line with the company's projections for 2008."

About Eastland Medical Systems Ltd

The development and manufacture of injection, infusion and blood-drawing devices.

Eastland Medical Systems Ltd




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
World Leaders In Infectious Diseases To Convene And Discuss Developments In Research, Prevention And Treatment
15 Nov 2008
Nearly 2,900 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 57th American Society of...


Involving Your Kids in Their Nutrition
Involving Your Kids in Their Nutrition

Nutrition experts recommend getting your kids involved in their nutrition decisions, and making sure they understand why good nutrition is important.

more videos are available in our health videos section.